XPZ-35

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameXPZ-35
Drug Alias NameXPZ-35
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin C inhibitors
TargetsCathepsin C
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUNIZYME Laboratories A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUNIZYME Laboratories A/S
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A